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Defects in mitochondrial ribosomal proteins (MRPs) cause various diseases in humans.
Because of the essential role of MRPs in synthesizing the essential subunits of oxidative
phosphorylation (OXPHOS) complexes, identifying all of the protein components involved
in the mitochondrial translational machinery is critical. Initially, we identified 79 MRPs;
however, identifying MRPs with no clear homologs in bacteria and yeast mitochondria
was challenging, due to limited availability of expressed sequence tags (ESTs) in
the databases available at that time. With the improvement in genome sequencing
and increased sensitivity of mass spectrometry (MS)-based technologies, we have
established four previously known proteins as MRPs and have confirmed the identification
of ICT1 (MRP58) as a ribosomal protein. The newly identified MRPs are MRPS37
(Coiled-coil-helix-coiled-coil-helix domain containing protein 1-CHCHD1), MRPS38 (Aurora
kinase A interacting protein1, AURKAIP1), MRPS39 (Pentatricopeptide repeat-containing
protein 3, PTCD3), in the small subunit and MRPL59 (CR-6 interacting factor 1, CRIF1) in
the large subunit. Furthermore, we have demonstrated the essential roles of CHCHD1,
AURKAIP1, and CRIF1in mitochondrial protein synthesis by siRNA knock-down studies,
which had significant effects on the expression of mitochondrially encoded proteins.
Keywords: mitochondrial translation, MRPS37 (CHCHD1), MRPS38 (AURKAIP1), MRPS39 (PTCD3), MRPL58 (ICT1),
MRPL59 (CRIF1), 55S, mitochondrial ribosomal proteins
INTRODUCTION
Mammalian mitochondria use oxidative phosphorylation
(OXPHOS) to provide more than 90% of the ATP used for energy
by cells. ATP production by this process depends on electron
transport chain complexes and ATP synthase, components of
which are encoded by both the nuclear and mitochondrial
genomes. In mammals, mitochondrial DNA encodes the infor-
mation for only 13 essential proteins required for OXPHOS, in
addition to 22 tRNAs and 2 rRNAs. The 13 proteins encoded
by the mitochondrial genome are synthesized on 55S ribosomes
using the specialized translational system within the organelle.
Mammalian mitochondrial ribosomes (55S) consist of small
(28S) and large (39S) subunits (O’Brien et al., 1993; Pel and
Grivell, 1994). The 55S ribosome is composed of ∼80 mito-
chondrial ribosomal proteins (MRPs), and all of these proteins
Abbreviations: MRPS, Mitochondrial ribosomal small subunit protein; MRPL,
Mitochondrial ribosomal large subunit protein; capLC-MS/MS, capillary liquid
chromatography-nanoelectrospray ionization-tandem mass spectrometry.
are encoded by nuclear genes and imported into mitochondria,
where they are assembled into the ribosome with mitochondri-
ally transcribed rRNAs (De Vries and Van Der Koogh-Schuuring,
1973; Pietromonaco et al., 1991; Koc et al., 2001a,b). About a
decade ago, we and others identified almost all of the proteins
present in these ribosomes using various proteomics techniques.
This initial analysis indicated that the small subunit of the ribo-
some contains 29 proteins, whereas the large subunit has about
50 proteins (Goldschmidt-Reisin et al., 1998; Graack et al., 1999;
Koc et al., 1999, 2001a,b; Suzuki et al., 2001). About half of the
proteins in mammalian mitochondrial ribosomes have homologs
in bacterial and yeast mitochondrial ribosomes and play a role
either in the assembly and structure of ribosomes or in the
initiation, elongation, or termination phases of mitochondrial
translation (Smits et al., 2007; Christian and Spremulli, 2011;
Koc and Koc, 2012). The functions and ribosomal locations of
the mitochondrial-specific proteins are not known; however, they
may replace some of the functions of bacterial ribosomal proteins
that are not present in the mitochondrial ribosome. They may
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also provide additional function(s) critical for protein synthesis or
its regulation in mammalian mitochondria (Koc et al., 2001a,b).
Although it is not possible to determine the exact locations of
these mitochondrial-specific proteins without x-ray structural
information, cryo-EM reconstruction studies indicate that they
are distributed on the exterior surface of the ribosome (Sharma
et al., 2003; Agrawal et al., 2011). It is clear that some of the
mitochondrial-specific ribosomal proteins are located in func-
tionally important regions of the ribosome, particularly at the
mRNA entrance gate in the small subunit and at the polypeptide
exit tunnel and central protuberance region of the large sub-
unit, creating specific structures on the mitochondrial ribosome
(Sharma et al., 2003; Agrawal et al., 2011).
In many instances, mitochondrial-specific ribosomal proteins
were initially identified based on distinct biological functions that
did not appear to be related to mitochondrial translation. For
example, mitochondrial-specific MRPs such as MRPS29 (DAP3-
death associated protein 3) and MRPS30 (PDCD9-programmed
cell death protein 9) were originally identified on the basis of
their involvement in apoptosis. MRPL37 and MRPL41 were also
reported to be involved in apoptosis (Carim et al., 1999; Koc
et al., 2001a,b; Levshenkova et al., 2004; Chintharlapalli et al.,
2005; Yoo et al., 2005). Human mutations in MRPs have been
reported and can have a variety of consequences (Galmiche et al.,
2011; Smits et al., 2011). Major mutations in MRPs can lead to
functional changes in mitochondrial translation and can be lethal
(Miller et al., 2004; Jacobs and Turnbull, 2005; Saada et al., 2007;
Galmiche et al., 2011; Rotig, 2011; Smits et al., 2011). Aberrantly
expressed MRPs are also observed in many different tumors,
including in breast cancer, gliomas, squamous cell carcinoma, and
osteosarcoma (Bonnefoy et al., 2001; Koc et al., 2001b; Mariani
et al., 2001; Miller et al., 2004; Lyng et al., 2006). Therefore, a
complete list of mitochondrial ribosomal proteins will be funda-
mental to our understanding of the mitochondrial translational
machinery and its contribution tomitochondrial ATP production
in health and disease.
In the present study, we re-evaluated protein components
of the mammalian mitochondrial ribosome using mass spec-
trometry (MS)-based proteomics and have established that five
previously known mitochondrial proteins are components of
the mitochondrial ribosome. These proteins are coiled-coil-
helix-coiled-coil-helix domain containing protein 1 (CHCHD1),
aurora kinase A interacting protein 1 (AURKAIP1), pentatri-
copeptide repeat-containing protein 3 (PTCD3), immature colon
carcinoma transcript 1 protein (ICT1) and CR-6 interacting
factor 1 [CRIF1, also known as growth arrest and DNA-damage-
inducible proteins-interacting protein 1 (Gadd45GIP1)]. Three
newly established mitochondrial ribosomal proteins (CHCHD1,
AURKAIP1, and PTCD3) were assigned to the small subunit
of the 55S ribosome, while ICT1 and CRIF1 were assigned to
the large subunit. We further confirmed the specific roles for
CHCHD1, AURKAIP1, and CRIF1 in mitochondrial translation
by siRNA knock-down studies in human cell lines.
MATERIALS AND METHODS
PREPARATION OF BOVINE MITOCHONDRIAL RIBOSOMAL SUBUNITS
Mitochondrial ribosomes from bovine liver were prepared using
a previously described method at high and low ionic strengths
and at several different detergent concentrations (Matthews et al.,
1982; Koc et al., 2001a,b; Spremulli, 2007). The high ionic
strength and detergent concentrations used the standard con-
ditions of 300mM KCl and 1.6% Triton-X100 (Yang et al.,
2010). For the preparation of mitochondrial ribosomes at low
salt and detergent conditions, mitochondrial lysates were pre-
pared in a buffer containing 50mMTris-HCl, pH 7.6, 40mMKCl,
20mM MgCl2, 6mM β-mercaptoethanol, 0.2% Triton X-100,
and 1mM phenylmethylsulfonyl fluoride (PMSF). The mito-
chondrial lysate (100 mg/mL) was layered onto a 34% sucrose
cushion (40mM KCl, 20mM MgCl2, 50mM Tris-HCl, pH 7.6,
6mM β-mercaptoethanol and 34% (w/w) sucrose). Samples were
centrifuged at 35,000 rpm for 16 h at 4◦C in a Beckman Type-50.2
rotor. The pellet was collected as crude mitochondrial ribosomes
and resuspended in a buffer prepared with 40mM KCl, 20mM
MgCl2, 20mM Tris-HCl pH 7.6, 1mM dithiothreitol (DTT),
and protease inhibitor cocktail from Sigma-Aldrich (containing
1.04mMAEBSF, 0.8μMAprotinin, 40μMBestatin, 14μME-64,
20μM Leupeptin, and 15μM Pepstatin A as the final concen-
trations). Samples were then subjected to centrifugation through
a 10–30% linear sucrose gradient in buffer containing 40mM
KCl, 20mM MgCl2, 50mM Tris-HCl pH 7.6, and 1mM DTT as
described (Matthews et al., 1982; Koc et al., 2001a,b; Spremulli,
2007). Fractions containing 55S ribosomes were combined, and
the ribosomes were collected by centrifugation at 40,000 rpm
for 16 h. The concentration of Mg2+ in the preparations was
reduced to 2mM by dialysis in order to dissociate ribosomes
into 28S and 39S subunits, and the samples were separated again
on a linear 10–30% sucrose gradient containing 2mM Mg2+ as
described (Matthews et al., 1982; Koc et al., 2001a,b; Spremulli,
2007). Highly purified 28S and 39S subunits were collected by
centrifugation at 40,000 rpm for 16 h.
IDENTIFICATION OF MITOCHONDRIAL RIBOSOMAL PROTEINS BY
MASS SPECTROMETRY
To identify the proteins of mammalian mitochondrial ribosomes,
approximately 0.5 A260 units of purified ribosomal 28S and 39S
subunits and 55S samples were separated on SDS-PAGE, and
corresponding protein bands were excised into at least thirty
equal gel pieces. The pieces were processed by performing in-
gel tryptic digestion using methods previously established in
our laboratory (Miller et al., 2008, 2009; Soung et al., 2009).
Tryptic digests were analyzed by capillary liquid chromatography-
nanoelectrospray ionization-tandem mass spectrometry (capLC-
MS/MS). Extracted tryptic peptides (3–5μL) were injected into
a peptide trap (Michrom peptide CapTrap, C8 like resin, 0.3 ×
1mm, 5μm) over a 3min interval at 10μL/min for online desalt-
ing and concentration. With the use of a six-port switching
valve, the peptide trap was then placed in-line with the analytical
column, a PicoFrit column (0.075 × 150mm) packed in-house
with Wide Bore C18 reverse phase resin (Supelco Co., 5μm,
300 Å). Tandem MS spectra of tryptic peptides were obtained
by collision-induced dissociation (CID) in an LTQ linear ion
trap mass spectrometer system (ThermoFinnigan) including a
Surveyor HPLC pump and a Surveyor Micro AS autosampler.
MS/MS spectra were processed by Xcalibur 2.0 and searched
against the nonredundant NCBI protein database and the
Swiss-Prot and UnitProtKB databases using the Mascot server.
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Additionally, the search was repeated using a bovine protein
sequence database generated in-house. The protein information
obtained from the database searches and the scores of mitochon-
drial ribosomal proteins that were observed in multiple bands
were compared. To increase the data quality, proteins with a
Mascot score lower than 45 were excluded from the list.
Ribosomal proteins were assigned to subunits according to
their abundance in 28S and 39S fractions. The Exponentially
Modified Protein Abundance Index (emPAI) score was calcu-
lated to compare the protein abundance in each sample (Ishihama
et al., 2005). In brief, the ratio of the unique parent ion number
observed in the analysis to the observable peptide number from in
silico digestion is used as PAI in the formula: emPAI = 10(PAI)−1.
The emPAI values were used to determine subunit distribution of
each protein identified in 28S, 39S, and 55S samples.
PREPARATIONOF CRUDE RIBOSOMES FROM HUMAN CELL LINES AND
ISOLATEDMITOCHONDRIA
HeLa cells were grown in Dulbecco’s Modified Eagle’s Medium
(DMEM) media (Cellgro, Mediatech Inc.) supplemented with
10% (v/v) bovine calf serum (Hyclone Laboratories) and
100 IU/ml penicillin and 100μg/ml streptomycin at 37◦C and
5% CO2 in a humidified atmosphere. For the whole cell lysate
preparation, approximately 4 × 107 HeLa cells were combined
and lysed in 2mL of buffer containing 50mM Tris-HCl, pH 7.6,
0.26M sucrose, 60mMKCl, 20mMMgCl2, 0.8mMEDTA, 2mM
DTT, 0.05mM spermine, 0.05mM spermidine, 1.6% Triton X-
100, and protease inhibitor cocktail from Sigma-Aldrich using a
Dounce homogenizer (Wheaton). In order to isolate mitochon-
dria, approximately 2 × 107 HeLa cells were resuspended in 1mL
of an isotonic mitochondrial buffer (MB) (210mM mannitol,
70mM sucrose, 1mM EDTA, 10mMHEPES-KOH pH 7.5), sup-
plemented with protease inhibitors (1mMPMSF and the protease
cocktail from Sigma-Aldrich described above), and then homog-
enized in a Dounce homogenizer on ice. The suspension was
centrifuged at 400 × g in a microcentrifuge (ThermoForma) at
4◦C. The pellet was resuspended in another 1mL of MB and
the 400 × g centrifugation was repeated. Supernatants were com-
bined and centrifuged at 10,000 × g at 4◦C for 10min to pellet
mitochondria. The mitochondrial pellets were lysed in a buffer
containing 0.26M sucrose, 20mM Tris-HCl, pH 7.6, 40mM KCl,
20mMMgCl2, 0.8mMEDTA, 0.05mM spermine, 0.05mM sper-
midine, 6mM β-mercaptoethanol, and 1.6% Triton X-100 using
a Dounce homogenizer.
To collect the crude ribosomes, whole cell and mitochondrial
lysates (2mL) were layered onto a 34% sucrose cushion (4mL)
in buffer (50mM Tris-HCl, pH 7.6, 60mM KCl, 20mM MgCl2,
and 6mM β-mercaptoethanol) and centrifuged in a Type 40 rotor
(Beckman Coulter) at 40,000 rpm for 16 h. The post-ribosomal
supernatant was fractionated into six separate layers (designated
L1–L6) for analysis, and the pellet was collected as a crude riboso-
mal fraction. The crude ribosome preparations, which included
mitochondrial and cytoplasmic ribosomes for whole cell lysates
and only mitochondrial ribosomes for the mitochondrial lysates,
were resuspended in 50μL of Base Buffer III (50mM Tris-HCl,
pH 7.6, 60mM KCl, 20mM MgCl2, 1mM DTT) and protease
inhibitor cocktail (Sigma-Aldrich). Ribosome suspensions were
stored at −80◦C for further analyses.
RNase A TREATMENT OF MITOCHONDRIAL RIBOSOMES
In order to confirm the direct or indirect interaction of newMRPs
with the rRNA of the mitochondrial ribosome, approximately ∼5
A260 units of a crude preparation of ribosomes obtained from
bovine liver were incubated in the absence or presence of 20μg
RNase A and loaded onto separate 10–30% linear sucrose gradi-
ents in buffer containing 40mMKCl, 20mMMgCl2, 50mMTris-
HCl, pH 7.6, and 1mM DTT. After centrifugation, the proteins
in equal volumes (25μL) of gradient fractions were separated on
12% SDS-PAGE. The proteins were transferred to PVDF mem-
branes and probed with corresponding antibodies as described
below.
IMMUNOBLOTTING
Ribosome samples collected from HeLa cell and bovine mito-
chondria (including sucrose gradient fractions, purified 55S
ribosomes, 28S subunits, and 39S subunits) were separated by
12% SDS-PAGE. Proteins were transferred to PVDF membranes,
which were probed with rabbit polyclonal anti-CHCHD1 anti-
body at a 1:1000 dilution (Abcam), rabbit anti-AURKAIP1 anti-
body at a 1:1000 dilution (Sigma-Aldrich), goat anti-CRIF1 anti-
body at a 1:500 dilution (Santa Cruz Biotechnology), mouse
monoclonal anti-MRPS29 (DAP3) and anti-HSP60 antibod-
ies at 1:5000 dilutions (BD Transduction Laboratories), mouse
anti-OXPHOS (MITOPROFILE®) at a 1:5000 dilution (Abcam
Inc.), or rabbit polyclonal human anti-MRPL47 and mouse
polyclonal human anti-MRPS18-2 antibodies at 1:5000 dilu-
tions (produced in-house) for 16 h at 4◦C. All of the sec-
ondary antibodies were used at 1:5000 dilutions, including
donkey anti-goat IgG (Santa Cruz Biotechnology) for CRIF1;
goat anti-mouse IgG (Pierce Biochemicals Inc.) for MRPS29,
HSP60 and OXPHOS, and goat anti-rabbit IgG for CHCHD1,
AURKAIP1, and MRPL47. The membranes were developed
using SuperSignal West Pico Chemiluminescent substrate (Pierce
Biochemicals Inc.) according to the protocol provided by the
manufacturer.
[35S]-METHIONINE PULSE LABELING OF MITOCHONDRIAL
TRANSLATION PRODUCTS IN VIVO
Human embryonic kidney 293T (HEK293T) cell lines were cul-
tured in DMEM (Cellgro, Mediatech Inc.) supplemented with
10% bovine calf serum (Hyclone), 100 IU/ml penicillin, and
100μg/ml streptomycin at 37◦C and 5% CO2 in a humidi-
fied atmosphere. Cells were transfected with control siRNA (sc-
44235) and mixtures of two to five target-specific siRNAs against
CHCHD1 (sc-90488), AURKAIP1 (sc-72472), and CRIF1 (sc-
97804) from Santa Cruz Biotechnology using Lipofectamine™
2000 (Invitrogen) according to the protocol provided by the
manufacturer. The transfected cells were grown in transfection
medium for 2 days prior to labeling with [35S]-methionine. It
should be noted that the siRNA treated cells grew very poorly
reflecting the importance of CHCHD1, AURKAIP1, and CRIF1
for cell growth and viability and suggesting that they play an
essential role in the cell. Labeling experiments were performed
in the presence of dialyzed serum (25mM Tris-HCl, pH 7.4,
137mM NaCl, and 10mM KCl) and minimum essential DMEM
medium, which does not contain methionine, glutamine, or cys-
teine, as indicated in our previous reports following the protocol
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by Chomyn et al., with several modifications described by Leary
et al. (Chomyn, 1996; Leary and Sasarman, 2009; Yang et al.,
2010). Cells were incubated with emetine-containing medium
for 5min to arrest cytosolic protein synthesis, and 0.2 mCi/mL
of [35S]-methionine (Perkin Elmer) containing medium was
then added to label the mitochondrially-encoded proteins. After
a 2 h incubation, cells were lysed in buffer containing 50mM
Tris-HCl, pH 7.6, 150mM NaCl, 1mM EDTA, 1mM EGTA,
0.1% SDS and 0.5% NP-40 supplemented with 1mM PMSF and
protease inhibitor cocktail (Sigma-Aldrich). Whole cell lysates
(40μg) were electrophoresed through 12% SDS-PAGE. The gels
were dried on 3MM chromatography paper (Whatman), and
the total intensities of the signals were quantified by phospho-
rimaging analyses (Jeffreys and Craig, 1976). The siRNAmediated
knock-down efficiency of the corresponding mitochondrial ribo-
somal protein was confirmed with immunoblotting analysis of
whole cell lysates or crude ribosomal fractions, prepared as stated
above.
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR)
Total RNA was isolated from siRNA transfected HEK293T cells
by using RNeasy Mini Kit from Qiagen. These RNA preparations
were tested for mtDNA contamination using a minus reverse
transcriptase control and shown to be free of mtDNA (data not
shown). The cDNA was synthesized using the ThermoScript™
RT-PCR system (Invitrogen). The primers used were: CHCHD1
forward 5′- ACCTCTCATTCTAGCTAACCGCGT -3′, reverse
5′- AGACTCTCCCAGGGTTTCCTGTAT -3′; AURKAIP1 for-
ward 5′- TCCACCGCAATCCTACCAGTGT -3′, reverse 5′- CG
AACTTGATCTGCTTGCGTCTCA -3′; CRIF1 forward 5′- GAT
GATTGTGAACTGGCAGCAGCA -3′, reverse 5′- CGCCTCCT
TCTTCCGTTTCTGTTT -3′; ND6 forward 5′- GAGTGTGGGT
TTAGTAATGGGGTTTGTGGGG -3′, reverse 5′- CCTATTCCC
CCGAGCAATCTC -3′; COI forward 5′- ATTTAGCTGACTCG
CCACACTCCA -3′, reverse 5′- TAGGCCGAGAAAGTGTTGTG
GGAA -3′; COII forward 5′- ATGGCACATGCAGCGCAAGTA
-3′, reverse 5′- CTATAGGGTAAATACGGGCCC-3′; ATP6 for-
ward 5′- TAATACGACTCACTATAGATGAACGAAAATATGT -
3′, reverse 5′- TTTTTTTTTTTTTTTTTTTTTTCATTGTTGGGT
GGTGATTAG -3′; 12s rRNA forward 5′- AATAGGTTTGGT
CCTAGCCTAGCC -3′, reverse 5′- GTTCGTCCAAGTGCACTT
TCCAG -3′; MRPS29 forward 5′- ATGGACCGACACGGGTAT
TGTACC -3′, reverse 5′- AAGGCCATGGGGAAATACAGTC -
3′; MRPL47 forward 5′- AAACGGGGTACCGAGATGGCTGCG
GCCGGTTTGGCCC -3′, reverse 5′- CCGCTCGAGTTAATGGT
GATGGTGATGATGGACAAGACTTGACTTTTGGGC -3′; glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH) forward 5′-
GTCTTCACCACCATGGAGAAGG -3′, reverse 5′- ATGAGGTC
CACCACCCTGTTGC -3′. Reactions were performed accord-
ing to the instructions provided by the manufacturer. Samples
were visualized using the ChemiDoc XRS system, employing
Quantity One® 1D analysis software (Bio-Rad). The signal inten-
sities obtained for control and siRNA knock-down samples were
normalized to the GAPDH signals for the relative quantitation of
RNA expression.
RESULTS AND DISCUSSION
IDENTIFICATION OF 55S RIBOSOMAL PROTEINS BY TANDEMMASS
SPECTROMETRY
The majority of the protein components of mammalian mito-
chondrial ribosomes were identified by our group, as well as
several other groups, a decade ago using proteomics strategies
(Goldschmidt-Reisin et al., 1998; Graack et al., 1999; Koc et al.,
1999, 2000, 2001a,b; O’Brien et al., 1999). However, due to the
limited availability of bovine or rat protein and DNA sequence
information, some of the ribosomal and ribosome-associated
proteins were not detected or identified by matching the tan-
dem MS data to the publicly available ESTs or protein databases
available at the time. An analysis of the protein composition of
a large macromolecular complex requires the preparation of that
complex under conditions that are strong enough to remove con-
taminants, but that are gentle enough to prevent the loss of more
loosely bound protein components. In order to re-evaluate their
protein composition and to eliminate transiently associated pro-
teins, mammalian mitochondrial ribosomes were purified under
two different salt and detergent conditions from bovine liver
(Figure 1) (Spremulli, 2007). The 10–30% linear sucrose gradient
separation of mitochondrial ribosomes was carried out at 20mM
Mg2+ to collect 55S particles (Figure 1).
The protein compositions of the 55S samples prepared under
the two different salt and detergent conditions were compared
by SDS-PAGE (Figure S1). In general, the gel pattern was simi-
lar in both ribosomal preparations; however, the sample prepared




























FIGURE 1 | Experimental scheme for the purification of
mitochondrial ribosomes and 28S and 39S subunits. To obtain
purified 55S ribosomes and 28S and 39S subunits using
sequential linear sucrose gradients, bovine mitochondrial lysates
were prepared at different ionic and detergent conditions to
remove mitochondrial metabolic enzymes co-sedimenting with the
mitochondrial ribosome. Experimental details are included in
Materials and Methods.
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lower amounts of high molecular weight proteins. The proteins
in these bands may be subunits of the large enzyme com-
plexes that co-sediment with the mitochondrial ribosome frac-
tions (Figure S1). The gels were sliced into thirty fractions, and
the in-gel tryptic digestion of each gel piece was analyzed by
capLC-MS/MS. The peptide and protein contents of the gels were
determined by matching MS/MS spectra to an in-house protein
sequence database, which was generated by the combination of
∼30,000 bovine proteins found in the Swiss-Prot and UniProtKB
databases.
A comprehensive list of the MRPs, the subunits of metabolic
enzyme complexes, and the other proteins identified in our anal-
yses is given in Tables S1 and S2. The list of the proteins that had
not previously been identified as bona fide ribosomal proteins was
created by excluding the known MRPs, mitochondrial metabolic
pathway proteins, and oxidative phosphorylation proteins. In
these analyses, CHCHD1, AURKAIP1, PTCD3, and CRIF1 were
repeatedly found to be present in the mitoribosome with high
confidence in both low and high salt and detergent preparations
(Tables 1, S2, S3). It should be noted that CRIF1 and PTCD3
were known from previous studies to be associated with the ribo-
some (Davies et al., 2009; Kim et al., 2012). ICT1 (MRPL58)
was also observed in these studies and was reported previously
as a mitochondrial ribosomal protein (Richter et al., 2010). With
the exception of large complexes of metabolic enzymes (specifi-
cally 2-oxoglutarate and pyruvate dehydrogenases and ATP syn-
thase F1 subunits sedimenting with the ribosome), proteins
consistently found in both low and high salt and detergent prepa-
rations of 55S ribosomes were considered as possible components
of the mitochondrial translational machinery and ribosomal pro-
teins (Tables 1, S1).
SUBUNIT ASSIGNMENTS OF RIBOSOME-ASSOCIATED PROTEINS BY
LC-MS/MS
In order to categorize the newly observed proteins as either
MRPs or proteins involved in translation, determining the sub-
unit assignments of these proteins was essential. Sucrose gradient
purified bovine 55S ribosomes prepared at high salt and deter-
gent conditions (Figure S1) were sedimented on a second 10–30%
linear sucrose gradient containing 2mMMg2+ to promote disso-
ciation of the small (28S) and large (39S) subunits (Figure 2A).
Proteins contained in the purified 28S, 39S, and 55S samples
were separated by SDS-PAGE and stained with Coomassie Blue
(Figure 2A). Although the amount of high molecular weight pro-
teins found in the 55S ribosome preparation decreased, several
remained associated with the 28S and 39S subunits in the second
sucrose gradient (Figure 2A). The Coomassie Blue stained gel
clearly showed the differential protein and MRP distribution in
the 28S and 39S fractions, and the 55S fraction contains the pro-
tein bands observed in both 28S and 39S fractions (Figure 2A).
Each lane was cut into thirty equal pieces. In-gel tryptic diges-
tions were carried out, and the resulting peptides were analyzed by
capLC-MS/MS. Database searches were performed as described
for the analysis of 55S ribosomal proteins.
In general, the same set of proteins found in the 55S ribo-
somes was also identified in 28S and 39S subunits (Table S1).
This table provides a complete list of the MRPs and the newly
Table 1 | Peptide sequences of new mitochondrial ribosomal proteins
identified from LC-MS/MS analyses of in-gel tryptic digestions of
28S, 39S, and 55S samples prepared at high salt conditions.
Name Sequence Score m/z Mr (expt)
CHCHD1 KPILKPNKPLILANHVGER 97 713.2 2136.7
SIQEDLGELGSLPPR 112 805.7 1609.4
SIQEDLGELGSLPPRK 85 870.4 1738.7
AURKAIP1 AGLKEAPPGWQTPK 74 740.7 14.79.4
EAPPGWQTPK 83 556.7 1109.6
PTCD3 DEGADIAGTEEVVIPK 113 821.7 1641.5
TWDKVAVLQALASTVHR 145 948.4 1894.9
VAVLQALASTVHR 88 683 1364.1
AGHQLGVTWR 63 563.4 1124.7
AHTQALSMYTELLNNR 143 931.9 1861.7
ADVHTFNSLIEATALVVNAK 150 1057.8 2113.7
WNNILDLLK 54 564.9 1127.9
QMVAQNVKPNLQTFNTILK 110 1094.5 2186.9
GSSLIIYDIMDEITGK 118 878.3 1754.6
FSPKDPDDDMFFQSAMR 72 723.6 2167.9
DPDDDMFFQSAMR 102 788.2 1574.4
DLELAYQVHGLLNTGDNR 124 1014.9 2027.9
LEMIPQIWK 55 579.4 1156.8
SDLKEEILMLMAR 91 775.4 1548.9
EEILMLMAR 51 553.6 1105.2
NELLNEFMDSAK 80 706.3 1410.5
ASSSPAQAVEVVK 79 636.7 1271.4
LTADFTLSQEQK 95 691 1379.9
EALGDLTALTSDSESDSDSDTSKDK 90 863.8 2588.4
ICT1 QGNDDIPVDR 90 565.3 1128.5
AGELILTSEYSR 79 670.4 1338.8
GADTAWRVPGDAK 60 672.6 1343.2
SAYSLDKLYPESR 95 766.3 1530.7
FHLASADWIAEPVR 119 806.8 1611.5
VPGDAKQGNDDIPVDR 69 565.6 1693.9
DMIAEASQPATEPSKEDAALQK 124 1165.9 2329.9
CRIF1 HGAASGVDPGSLWPSR 115 797.5 1593.1
AAAMAAAAAQDPADSETPDS 116 930.9 1859.8
EQLLELEAEER 77 680.3 1358.6
MPQMIENWR 54 602.9 1203.8
FQELLQDLEK 62 632.3 1262.7
identified proteins, as well as their distributions in the 28S
and 39S subunits. The proteins transiently associated with the
55S ribosome (including mitochondrial elongation factor EF-Tu,
ribosome recycling factor (RRF), and a bacterial yBEB homolog,
C7orf30) were released during either the 55S ribosome prepa-
ration or the dissociation of the ribosome into 28S and 39S
subunits in the second sucrose gradient at 2mM Mg2+ (Table
S1). Four additional proteins not previously assigned as mito-
chondrial ribosomal proteins (CHCHD1, AURKAIP1, PTCD3,
and CRIF1) were consistently observed in 28S or 39S subunits
and in 55S ribosomes, making the determination of whether these
proteins are bona fide ribosomal proteins or ribosome-associated
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FIGURE 2 | Identification and detection of mitochondrial ribosomal
proteins and their subunit association by capLC-MS/MS and
immunoblotting analyses. (A) Purified mitochondrial (55S) ribosomes (∼10
A260) prepared in high salt conditions were dissociated into subunits by
sedimentation through a second 10–30% linear sucrose gradient in the
presence of 2mM Mg2+ as described in Figure 1. After the sedimentation of
the purified subunits, the same A260 units of 28S and 39S subunits and 55S
ribosomes (∼0.5) were separated on SDS-PAGE. The gel was cut into 30
pieces for in-gel digestion of protein bands with trypsin and the peptides were
analyzed by capLC-MS/MS analysis to identify the proteins present. Gel
fractions containing the peptides detected from newly identified MRPs are
marked on the image. Proteins identified in these gel pieces are given in
Tables S1, S2. (B) Purified 28S and 39S subunits (∼0.2 A260) were obtained
from the dissociation of purified 55S ribosomes as described in Materials and
Methods at 2mM Mg2+. Proteins present in these preparations were
separated on 12% SDS-PAGE and analyzed by immunoblotting using
CHCHD1, AURKAIP1, CRIF1, MRPS29, and MRPL47 antibodies to confirm
subunit distribution of new MRPs. (C) To confirm the ribosome association of
newly identified proteins, crude mitochondrial ribosomes prepared at high salt
and detergent conditions were separated on a 10–30% linear sucrose gradient
in the presence of 20mM Mg2+ as described in Figure 1. Distribution of new
proteins, CHCHD1, AURKAIP1, and CRIF1, were detected by immunoblotting
analyses of sucrose gradient fractions containing dissociated ribosomal
subunits (28S and 39S) and 55S ribosomes. Antibodies against two 28S
subunit proteins, MRPS18B and MRPS29, and a 39S protein, MRPL47, were
used to indicate the locations of the subunits and the 55S ribosome.
proteins critical. The relative molecular masses of these proteins
were in good agreement with their expected molecular weights
after the removal of mitochondrial import signals (Figure 2A)
(Claros and Vincens, 1996). The Mascot scores obtained from
database analyses of these peptides revealed that these proteins
have clear subunit distributions in either the 28S or 39S sub-
unit, except for ICT1 (Table S1). In addition to the Mascot scores
obtained for each protein, the experimental emPAI scores deter-
mined as described by Ishihama et al. (Ishihama et al., 2005) were
calculated to demonstrate the relative protein abundance in each
subunit, using the ratio of peptides detected by capLC-MS/MS
analyses to the number of observable peptides obtained from in
silico digestion of a protein (Tables 2, S1, S3). The GenBank™
and Swiss-Prot access numbers of the newly identifiedMRPs used
in the emPAI determination are listed in Table 3. The agreement
between the emPAI scores for the 55S ribosome and either the
28S or 39S values for each protein clearly shows that these pro-
teins were associated with the ribosome and its subunits under
the conditions used in our experiments (Table 2). Variations in
emPAI scores, specifically for PTCD3 and ICT1, could be due to
discrepancies in the excision of gel slices, and the extraction of
peptides in different samples, or the data dependent acquisition
of peptides by the capLC-MS/MS system.
To confirm the subunit distribution determined by the emPAI
scores, immunoblotting analyses of purified subunits and 55S
ribosomes were performed using CHCHD1, AURKAIP1, and
CRIF1 antibodies. Previous work had indicated that PTCD3
was associated with the small subunit, while CRIF1 and ICT1
interacted with the large subunit (Koc and Spremulli, 2003;
Richter et al., 2010; Haque et al., 2011; Kim et al., 2012). In the
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present analyses, CHCHD1 and AURKAIP1 signals overlapped
with the MRPS29 signals, which were clearly detected in 28S and
55S fractions, indicating their association with the small subunit.
CRIF1 was detected in 39S and 55S preparations, along with the
large subunit proteinMRPL47 (Figures 2B,C). The data obtained
by capLC-MS/MS and immunoblotting analyses cooperatively
suggest that CHCHD1 and AURKAIP1 are newly described com-
ponents of the small subunit. Further, the data indicate that
CRIF1 is not only associated with the large subunit, but also a
bona fide component of the large subunit of the mitochondrial
ribosome. Alignments of new MRPs across worm, fly, mouse,
bovine, and human homologs (as well as yeast homologs of
CHCHD1 and AURKAIP1) indicate the presence of evolutionar-
ily conserved regions in these new proteins (Figure S2). Some of
the characteristics of these new ribosomal proteins are described
below.
CHCHD1
Although a signal peptide cleavage site was not predicted by
MitoProt II, the probability of a mitochondrial localization of
bovine CHCHD1 is 81% (Claros and Vincens, 1996). The acces-
sion numbers for CHCHD1 from various organisms, used in
the alignment of the full length sequences, are given in Table 3
(Figure S2). The full length bovine CHCHD1 is about 13.6 kDa.
Mass spectrometry analysis of tryptic peptides extracted from
the protein bands excised from 28S, 39S, and 55S lanes resulted
in identification of CHCHD1 peptides in 28S and 55S sam-
ples, but not in 39S subunits (Tables 1, S1). Mammalian mito-
chondrial CHCHD1 has a homolog in the yeast mitochondrial
ribosome, MRP10, as reported by Smits et al., which has about
20% sequence identity to the human protein (Graack et al.,
1992; Jin et al., 1997). Similarly, the fly and worm homologs of
Table 2 | Relative distribution of new mitochondrial ribosomal
proteins using emPAI (Exponentially Modified Protein Abundance
Index) values calculated from peptides detected by LC-MS/MS
analyses of proteins in 28S and 39S subunits and 55S ribosomes.
Subunit CHCHD1 AURKAIP1 PTCD3 ICT1 CRIF1
28S 3.30 0.27 169.61 0.97 0.49
39S ND 0.19 0.64 1.09 2.02
55S 3.14 0.27 22.77 0.86 2.11
Peptides (ion score cut off of ≥45) listed in Table S3 were used in emPAI
calculations. ND; not detected.
CHCHD1 are also 20–25% identical to mammalian homologs,
although their sequence identity to the yeast homolog is below
14% (Figure S2). The emPAI values calculated using CHCHD1
peptides clearly suggest that this protein is mainly associated with
the small subunit of mitochondrial ribosomes (Tables 2, S3). The
data presented here provide the first experimental evidence indi-
cating that CHCHD1 is a component of the small subunit in
mammalian mitochondria.
AURKAIP1
AURKAIP1, also known as Aurora-A-interacting protein (AIP),
was first described as a regulator of Aurora-A kinase, which is a
Ser/Thr kinase involved in cell cycle progression and tumorigene-
sis (Kiat et al., 2002). The homology region found in AURKAIP1
homologs is termed DUF1713, and this region is found in the
C-terminal domain of yeast COX24 (Figure S2). Yeast COX24
was described as one of the factors responsible for COI mRNA
processing and translation (Barros et al., 2006). The calculated
molecular mass of the full-length AURKAIP1 is 22.4 kDa; how-
ever, themature protein migrates at about 16 kDa (Figures 2B, 3).
It is possible that AURKAIP1 has a longer signal peptide than the
predicted signal peptide, which provides a 99% likelihood for the
translocation of this protein into mitochondria. Translocation of
AURKAIP1 into the mitochondria has also been experimentally
validated by the Human Protein Atlas (HPA) project (Uhlen et al.,
2010). AURKAIP1 was repeatedly detected in the capLC-MS/MS
analyses of low and high salt preparations of bovine mitochon-
drial ribosomes and their subunits. The calculated emPAI values
for peptides obtained from purified 28S and 39S preparations
suggest the association of AURKAIP1 with the small subunit, con-
sidering that the emPAI value for the 28S subunit is 30% higher
than that of the 39S subunit (Tables 1, 2, S1, S3).
PTCD3
We first reported PTCD3 as an mRNA-binding protein associ-
ated with the 28S subunit and as a possible PET309 homolog, due
to the presence of pentatricopeptide repeats (Koc and Spremulli,
2003). The association of PTCD3 with the small subunit and its
essential role in mitochondrial translation has also been reported
(Davies et al., 2009). Our data not only confirms the association of
PTCD3 with the small subunit, but also provides evidence that it
is a bona fide ribosomal protein. This idea was recently reinforced
by the observation that PTCD3 is one of the 28S subunit pro-
teins that interacts with mitochondrial initiation factor 3 (Haque
et al., 2011). The full-length bovine PTCD3 is 77.8 kDa with a
pI of 6.0; it is possibly the largest protein, and one of the most
Table 3 | GenBank™ and Swiss-Prot accession numbers of new mitochondrial ribosomal proteins found in various species.
MRP Protein Human Bovine Mouse Fly Worm
MRPS37 CHCHD1 Q96BP2 Q2HJE8 XP_852408 ABJ16982 AAB88317
MRPS38 AURKAIP1 Q9NWT8 Q0VCJ1 XM_843641 Q8IML6 Y54G9A
MRPS39 PTCD3 Q96EY7 Q2KI62 XP_532975 A1Z9A8 AAF60413
MRPL58 ICT1 Q14197 Q3T116 XP_533118 CAL26738 AAL06045
MRPL59 CRIF1 Q8TAE8 A1A4P4 XP_533898 AAM29650 CAB03171
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FIGURE 3 | Sedimentation of new MRPs with large complexes in human
cell lines and mitochondria. (A) Whole cell lysate (WCL) and (B)
mitochondrial lysate (MITO) obtained from human cell lines were layered on
sucrose cushion preparations. After 16h centrifugation, post-ribosomal
supernatant layers (Layers 1 to 6) and the crude ribosome pellet (P) were
collected and analyzed by immunoblotting probed with CHCHD1, AURKAIP1,
CRIF1, MRPS29, MRPL47, and HSP60 antibodies. (C) To confirm the
RNA-dependent association of new MRPs with mitochondrial ribosomes, the
same amount of crude ribosomes, both Control and RNase A-treated, were
sedimented on 10–30% sucrose gradients. Equal volumes of sucrose gradient
fractions were separated on 12% SDS-PAGE. Sedimentation of new MRPs
with ribosomal subunits and 55S ribosomes in the absence and presence of
RNase A was analyzed by immunoblotting using CHCHD1, AURKAIP1, CRIF1,
MRPS29, andMRPL47 antibodies. HSP60 immunoblotting and the Coomassie
Blue stained gel are shown as controls for multimeric mitochondrial complexes
sedimenting with the 55S ribosome in control and RNase A-treated gradients.
acidic components of the 55S ribosome. It is highly conserved
among its animal mitochondrial homologs (Figure S2). PTCD3
is a larger protein and has a lower pI compared to the basic
proteins of the mitochondrial ribosome, and nineteen unique
peptides were detected in its capLC-MS/MS analyses (Tables 1,
S3). In agreement with earlier observations, PTCD3 peptides
were mainly detected in protein bands excised from 28S and 55S
lanes (Figure 2A and Table S3). Its subunit localization is also
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supported by the emPAI values shown in Table 2; specifically,
the high experimental emPAI value for peptides identified in the
28S subunit sample, as well as in the 55S sample, indicates that
PTCD3 is a ribosomal component associated with both the 28S
subunit and 55S ribosomes (Tables 2 and S3). The presence of a
trace amount of PTCD3 in 39S preparations could be due to the
presence of a small amount of 28S subunits in the large subunit
fractions analyzed. This cross-contamination is common because
there is a tendency for the 55S ribosome to dissociate somewhat
during sucrose gradient centrifugation (Koc et al., 2001b). The
high emPAI scores of the 28S subunit and 55S ribosomes enabled
us to conclude that PTCD3 is a mitochondrial-specific MRP that
is mainly associated with the 28S subunit.
ICT1
Our data confirm previous reports that ICT1 is a mitochondrial
ribosomal protein. This protein belongs to the polypeptide release
family of proteins, and it is the first example of an integral com-
ponent of the large subunit providing peptidyl-tRNA hydrolase
activity (Richter et al., 2010). ICT1 is essential for the hydrol-
ysis of peptidyl-tRNAs on prematurely terminated mRNAs that
lack a stop codon (Handa et al., 2010; Richter et al., 2010). It is
a highly conserved protein among animals (Figure S2). Tryptic
peptides detected by capLC-MS/MS analyses of protein bands are
listed in Tables 1 and S3. ICT1 peptides were detected in 28S,
39S, and 55S samples, which made the calculated emPAI values
of the ICT1 in 28S and 39S subunits very close to each other
(Table S3). The experimental emPAI scores were not sufficiently
different to assign ICT1 to a particular subunit (Table 2). The
human ICT1 was previously shown to be associated with the
large subunit (Richter et al., 2010); however, our MS data do
not clearly support association of ICT1 with the large subunit
(Table 2). It is reasonable to suggest that ICT1 is located near
the interface region of the large subunit, and that a fraction of
ICT1 also sediments with the small subunit when the subunits are
dissociated.
CRIF1
CR-6 interacting factor 1 (CRIF1), which is also known as growth
arrest and DNA-damage-inducible proteins-interacting protein 1
(Gadd45GIP1), was identified as a transcriptional co-activator.
The calculated molecular mass of the full-length bovine CRIF1
is 25.7 kDa. Its mitochondrial localization signal peptide is pre-
dicted to be in the first 28 amino acid residues, and it has a 90%
possibility of mitochondrial localization (Figure S2). The calcu-
lated molecular mass for the mature CRIF1 is 22.9 kDa, and this
value is in agreement with the migration of the protein in SDS-
PAGE detected by capLC-MS/MS (Figure 2A). The emPAI values,
calculated from five unique CRIF1 peptides detected in 39S and
55S samples, strongly suggest that the mitochondrial CRIF1 is a
large subunit protein (Tables 2 and S3).
SUBFRACTIONATIONOF CHCHD1, AURKAIP1, AND CRIF1 WITH
MITOCHONDRIAL RIBOSOMES
In the capLC-MS/MS analyses of highly purified bovine mito-
chondrial ribosomes and subunits presented above, we were able
to assign the subunit in which the newly identified ribosomal
proteins were present. Association of PTCD3 and ICT1 with
the mitochondrial ribosome was reported in our earlier studies
and by other groups (Koc and Spremulli, 2003; Richter et al.,
2010). However, we are describing and characterizing CHCHD1,
AURKAIP1, and CRIF1 as integral components of the mitochon-
drial ribosome for the first time. Ectopically expressed forms of
CRIF1 and AURKAIP1 have been localized to the nucleus and
cytosol and reported to be involved in the transcriptional acti-
vation and regulation of Aurora-A kinase in human cell lines,
respectively (Kang et al., 2010). In order to evaluate their asso-
ciation with the mitochondrial ribosome, human whole cell and
mitochondrial lysates were prepared under non-denaturing con-
ditions and centrifuged through a 34% sucrose cushion, a step
analogous to that used in the preparation of bovine liver mito-
chondrial ribosomes (Figures 3A,B). This process enriched the
multimeric complexes resistant to high salt and non-ionic deter-
gent treatments in the bottom layer and pellet, mainly as cytoplas-
mic 80S and mitochondrial 55S ribosomes. In immunoblotting
analyses of post-ribosomal supernatant layers and crude riboso-
mal pellets obtained from the whole cell (Figure 3A) and mito-
chondrial lysates (Figure 3B), these MRPs were found mainly
in the pellet along with two mitochondrial ribosomal proteins
(MRPS29 and MRPL47), thus, confirming their co-localization
with the mitochondrial ribosome or other large complexes in
mitochondria.
Immunoblotting analyses and identification of these proteins
in highly purified ribosomal subunits, 55S ribosomes (Figure 2),
and crude ribosomes (Figure 3B) support their ribosome asso-
ciation; however, it is possible that these proteins could be asso-
ciated with the large mitochondrial complexes that co-sediment
with the ribosome but have nothing to do with mitochondrial
translaiton. For example, we have observed that polypeptides
of the oxoglutarate dehydrogenase complex can be detected in
the 28S region of the gradient. To demonstrate that the pro-
teins under study here are not simply co-sedimenting with the
ribosome but are actually associated with the particle, RNase
A-treatment of the 55S ribosome was carried out prior to load-
ing the samples onto the sucrose gradients and immunoblot-
ting analyses. RNase A-treatment destroys the integrity of the
mitochondrial ribosome (Figure 3C), as it does other ribo-
somes, as indicated by the loss of the A260 from the 55S region
of the sucrose gradient following nuclease treatment and the
increase in the A260 near the top of the gradient. As shown
in Figure 3C, the signals from the new MRPs overlapped with
those from MRPS29 and MRPL47 in the control sucrose gra-
dient fractions. When the ribosome sample was treated with
RNase, signals from CHCHD1, AURKAIP1, and CRIF1 disap-
peared from the 55S region of the gradient as did the signals
from the two control proteins, MRPS29 and MRPL47. This data
indicates that these proteins are either assembled into the ribo-
some or strongly associated with the mitoribosome and are not
simply co-fractioning with the 55S particles on the sucrose gradi-
ent. On the other hand, the HSP60 signal remained unchanged
in these fractions, along with high molecular weight proteins
which were subunits of the other multimeric complexes of
mitochondria detected by Coomassie Blue stained SDS-PAGE
(Figure 3C).
www.frontiersin.org July 2013 | Volume 4 | Article 183 | 9
Koc et al. Mammalian mitochondrial ribosomes: revisited
ROLE OF CHCHD1, AURKAIP1, AND CRIF1 IN MITOCHONDRIAL
TRANSLATION
To investigate the role of newly identified MRPs in mitochondrial
translation, we first transfected the HEK293 cells using control
and specific siRNAs corresponding to CHCHD1, AURKAIP1,
and CRIF1 mRNAs. The siRNA knock-down efficiency was
determined by RT-PCR analyses using total RNA isolated from
each cell line. In addition to the effect of siRNA knock-down
on CHCHD1, AURKAIP1, and CRIF1 mRNA expression, we
also determined the changes in expression of several nuclear
encoded MRPs and mitochondrially encoded genes (Figure 4A).
In specific siRNA knock-down cells, CHCHD1 and CRIF1mRNA
levels were reduced by 70% of the control siRNA knock-down
cells, whereas the reduction in AURKAIP1mRNA was about 85%
(Figure 4A). Clearly, none of the nuclear encoded MRP mRNAs
or the representative mitochondrially encoded mRNAs (ND6,
COI, COII, ATP6, and 12S rRNA) were affected by the reduc-
tion in CHCHD1, AURKAIP1, or CRIF1 mRNAs (Figure 4A).
Treatment with the specific siRNAs lead to the reduced expression
(from 55 to 75%) of the corresponding CHCHD1, AURKAIP1,
and CRIF1 proteins, as confirmed by immunoblotting analyses of
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FIGURE 4 | Role of CHCHD1, AURKAIP1, and CRIF1 knock-down on
mitochondrial protein synthesis. (A) Transcript levels of CHCHD1,
AURKAIP1, and CRIF1 were shown as an indication of knock-down efficiency
in cell lines transfected with control siRNA and siRNAs for corresponding new
MRPs. Mitochondrial encoded ND6, COI, COII, ATP6, and 12S rRNA, and
nuclear encoded MRPS29 and MRPL47 were examined by RT-PCR reactions
in the same samples. RT-PCR reactions with GAPDH were performed as a
positive control and relative quantitation of signal intensities was calculated
based on GAPDH mRNA levels (or siRNA control cell line) in each knock-down
cell line. (B) Expression levels of newMRPs in control siRNA andMRP-specific
siRNA transfected HEK293T cell lysates and total crude ribosome fractions (∗)
were analyzed by immunoblotting using antibodies against AURKAIP1,
CHCHD1, CRIF1, MRPS29, MRPL47, and HSP60. Immunoblotting analyses
with HSP60, MRPS29, and MRPL47 antibodies were used as loading controls
for total protein and total ribosome content using whole cell lysates obtained
from control and AURKAIP1 siRNA knock-down cells. Similar results were
obtained with immunoblotting analyses of total crude ribosome fractions from
CHCHD1 and CRIF1 siRNA knock-down cell lines using HSP60, MRPS29, and
MRPL47 antibodies (data not shown). (C) De novo synthesis of mitochondrial
proteins was evaluated in control siRNA and the siRNA of corresponding
MRPs transfected HEK293T cells by pulse labeling of proteins in the presence
of [35S]-methionine and a cytosolic translation inhibitor, emetine. A
representative electrophoretic pattern of the de novo synthesized translational
products is presented. ND1, −2, −3, −4, −4L, −5, and −6 are subunits of
Complex I; Cytb is a subunit of Complex III; COI, −II, and −III are subunits of
Complex IV; ATP6 and ATP8 are subunits of Complex V. Coomassie blue
staining of the same gel was performed to ensure equal protein loading in the
gel. (D) The combined intensities of the 13 mitochondrially-encoded proteins
from each lane were used as an overall quantitation of mitochondrial protein
synthesis from three separate experiments. (E) Immunoblotting analysis of
whole cell lysates prepared from control siRNA and MRP specific siRNA
transfected HEK293T cells was performed to examine the steady state levels
of the mitochondrial encoded subunit of Complex IV (COII) and nuclear
encoded subunits of Complex V (ATP5A), III (UQCRC2), and II (SDHB). The
arrow shows the reduced translation of mitochondrial encoded protein COII in
cell lines transfected with CHCHD1, AURKAIP1, and CRIF1 specific siRNAs.
The same PVDF was reprobed with MRPS29, MRPL47, and HSP60 antibodies
to ensure equal loading.
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lines using corresponding antibodies (Figure 4B). Since changes
in the expression of the newly identified MRPs by siRNAs had
no effect on the expression of mitochondrially encoded mRNAs
and rRNAs, the newly identified proteins are not directly involved
in transcription or RNA processing in mammalianmitochondria.
Furthermore, the presence of normal amounts of the 12S rRNA
indicates that there is no defect in the synthesis or assembly of the
mitoribosome suggesting that CHCHD1, AURKAIP1, and CRIF1
are unlikely to be proteins involved in ribosome assembly.
Given the association of new MRPs with the mitochon-
drial ribosome, we next examined the role of CHCHD1,
AURKAIP1, and CRIF1 knock-downs on the de novo synthesis of
mitochondrially-encoded proteins by [35S]-methionine labeling
in the presence of the cytosolic protein synthesis inhibitor eme-
tine. In this analysis, only the thirteen essential subunits of the
OXPHOS complexes synthesized by the mitochondrial transla-
tional machinery were labeled by [35S]-methionine (Figure 4C).
In cells transfected with CHCHD1, AURKAIP1, and CRIF1
siRNAs, relative mitochondrial protein synthesis was decreased
by 27, 48, and 22%, respectively, whereas the total protein con-
tent of the cell lysates was comparable (Figures 4C,D). Clearly,
the inhibition of protein synthesis in knock-down cells was due
to a reduction in expression of new MRPs, because reprob-
ing the same membrane with MRPS29, MRPL47, and HSP60
antibodies displayed no significant difference in ribosomal or
mitochondrial protein levels (Figure 4E). Although a consid-
erable amount of new MRPs remained in siRNA knock-down
cells (Figure 4B), the 22–48% reduction in overall mitochondrial
translation is significant. In addition to the decrease in pulse
labeling of mitochondrially encoded proteins, the steady state
levels of the mitochondrially encoded subunit of Complex IV,
COII, was also reduced in cells transfected with MRP-specific
siRNAs, as detected by immunoblotting analysis (Figure 4E).
On the other hand, the nuclear encoded subunits of oxidative
phosphorylation complexes, such as Complex V subunit ATP5A,
Complex III subunit Core II subunit (UQCRC2), and Complex
II SDHB subunit, remained unchanged (Figure 4E). Altogether,
these observations strongly suggest that CHCHD1, AURKAIP1,
and CRIF1 all have essential roles in mitochondrial protein syn-
thesis as components of the small and large subunits of the 55S
ribosome.
NOMENCLATURE
The two-dimensional gel analysis of bovine mitochondrial ribo-
somes lead to the prediction of as many as 33 ribosomal proteins
in the 28S subunit and 52 ribosomal proteins in the 39S subunit
(Koc et al., 2001a,b). These proteins were designated S1 through
S33 for the 28S subunit and L1 through L52 for the 39S subunit,
in order of decreasing molecular weights (Pietromonaco et al.,
1991). Later, we and several other groups identified 29 and 49
MRPs in the small and large subunits, respectively, using pro-
teomic analyses (Goldschmidt-Reisin et al., 1998; Graack et al.,
1999; Koc et al., 1999, 2001a,b; Suzuki et al., 2001; Yang et al.,
2010). To provide consistency for designation of the same pro-
teins in different organisms, we adopted a system of nomenclature
in which proteins with prokaryotic homologues are given the
same number as the corresponding ribosomal protein in E. coli.
Proteins without bacterial homologs are given the next available
number. Bacterial ribosomes have proteins designated S1 through
S21 in the 28S subunit and L1 through L36 in the large sub-
unit. Additionally, previously identified mammalian ribosomal
proteins without bacterial homologs were designated S22 through
S36 for the 28S subunit and L37 through L57 for the 39S subunit,
including a new number for MRP63 (MRPL57), because its asso-
ciation with the 39S subunit was not previously known (Table 4)
(Kenmochi et al., 2001). As a result, we proposed that the newly
identified small subunit proteins (CHCHD1, AURKAIP1, and
PTCD3) be named MRPS37, MRPS38, and MRPS39 and that
ICT1 and CRIF1, as newly identified large subunit proteins, be
designated asMRPL58 andMRPL59, respectively (Table 4). Here,
the adaptation of the new MRP numbers is absolutely critical for
their classification as mitochondrial ribosomal proteins and for
further investigation of their roles in mitochondrial translation
and biogenesis.
POTENTIAL ROLES OF NEWMITOCHONDRIAL RIBOSOMAL PROTEINS
IN TRANSLATION
Ribosomal proteins have roles in ribosome assembly, substrate
binding, and different stages of translation, such as initiation,
elongation, and termination. Furthermore, they are likely to inter-
act with the nascent chain and facilitate their insertion into the
respiratory chain complexes in the mitochondrial inner mem-
brane. The MRPs with bacterial homologs are expected to have
conserved functions in ribosome structure and translation. For
the mammalian mitochondrial-specific proteins without known
homologs in other ribosomes, it is highly challenging to identify
and assign whether a ribosome-associated protein is a genuine
ribosomal protein or a factor transiently associated with the ribo-
some. In fact, a recent bioinformatics survey of the evolutionarily
conserved ribosomal proteins failed to identify several additional
components of the mammalian mitochondrial ribosome (Smits
et al., 2007). The criteria used in this study, however, allowed us
to characterize the newly identified proteins as mitochondrial-
specific ribosomal proteins. One issue that arises in these studies
is to assess whether a protein observed in the ribosome prepa-
rations is a bona fide ribosomal protein or represents a protein
transiently associated with the ribosome. Several criteria can be
applied in making this determination. First, the newly assigned
protein must have a distribution that parallels that of known ribo-
somal proteins and changes in accordance with the distribution of
ribosomal proteins as the subunits are associated or dissociated.
The proteins should also be associated with the ribosomal parti-
cles when they are prepared under a variety of salt and detergent
conditions. This criterion is met by the newly assigned proteins
under study here. Second, the majority of the protein should be
present in fractions containing the ribosome, and there should
be little or no free pool of the protein. This criterion is met by
the majority of the known MRPs, although there are exceptions,
including MRPL12, which is known to have a free pool of pro-
tein that may interact with RNA polymerase. Examination of
the distribution of the new MRPs classified here indicates that
this criterion is also met. Proteins involved in processes such as
ribosome assembly generally show a distribution in which only a
portion of the total protein is found in the ribosome fraction. For
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Table 4 | List of mammalian mitochondrial ribosomal proteins with their bacterial homologs.
28S proteins 30S proteins New class 39S proteins 50S proteins New class 50S proteins
Missing S1 MRPS22 MRPL1 L1 MRPL33 L33
MRPS2 S2 MRPS23 MRPL2 L2 MRPL34 L34
MRPS24 S3 MRPS24 MRP-L3 L3 MRPL35 L35
Missing S4 MRPS25 MRPL4 L4 MRPL36 L36
MRPS5 S5 MRPS26 Missing L5 MRPL37
MRPS6 S6 MRPS27 Missing L6 MRPL38
MRPS7 S7 MRPS28 MRPL12 L7/L12 MRPL39
Missing S8 MRPS29 MRPL9 L9 MRPL40
MRPS9 S9 MRPS30 MRPL10 L10 MRPL41
MRPS10 S10 MRPS31 MRPL11 L11 MRPL42
MRPS11 S11 MRPS32 (MRPL42) MRPL13 L13 MRPL43
MRP-S12 S12 MRPS33 MRPL14 L14 MRPL44
Missing S13 MRPS34 MRPL15 L15 MRPL45
MRPS14 S14 MRPS35 MRPL16 L16 MRPL46
MRPS15 S15 MRPS36 MRPL17 L17 MRPL48
MRPS16 S16 MRPS37 (CHCHD1) MRPL18 L18 MRPL49
MRPS17 S17 MRPS38 (AURKAIP1) MRPL19 L19 MRPL50
MRPS18-1 S18 MRPS39 (PTCD3) MRPL20 L20 MRPL51
MRPS18-2 S18 MRPL21 L21 MRPL52
MRPS18-3 S18 MRPL22 L22 MRPL53
Missing S19 MRPL23 L23 MRPL54
Missing S20 MRPL24 L24 MRPL55
MRPS21 S21 Missing L25 MRPL56
MRPL27 L27 MRPL57 (RP_63)
MRPL28 L28 MRPL58 (ICT1)




example, less than half of C7orf30, which is involved in the assem-
bly of the large subunit, is observed associated with ribosomes
(Rorbach et al., 2012). Similarly, a significant fraction of ERAL1
involved in the assembly of the small subunit is also observed in
the non-ribosomal fraction of mitochondria (Dennerlein et al.,
2010).
Third, the preparations studied should have few peptide sig-
nals from proteins that are known to be transiently associated
with the ribosome. In our analysis, slight signals were detected
from elongation factor Tu and C7orf30. However, no peptides
were detected from many other proteins known to be associated
with the ribosome, including elongation factor G, initiation factor
2, initiation factor 3, OXA1L, ObgH1, and Mtg1. Thus, the bulk
of the evidence indicates that CHCHD1, CRIF1, and AURKAIPI
are, indeed, ribosomal proteins.
With the newly identified MRPs, the number of mammalian
mitochondrial ribosomal proteins is brought to 31 for the small
subunit and is increased to 51 for the large subunit (Koc et al.,
2000, 2001a,b; Suzuki et al., 2001; O’Brien et al., 2005) (Table 4).
It is not feasible to assign specific roles for the majority of
mitochondrial-specific proteins without structural information
and their relative locations in the ribosome; however, many of
them have been shown to be essential for mitochondrial pro-
tein synthesis and function. For instance, the yeast homologue of
MRPS37 (CHCHD1), MRP10, was discovered to be indispens-
able for mitochondrial translation. A respiratory defect caused
by a null mutant of MRP10 was recovered by the reintroduction
of the MRP10 gene into a wild-type mitochondrial DNA back-
ground (Jin et al., 1997). Similarly, MRPS38 (AURKAIP1) is a
possible homolog of yeast COX24p, which is involved in the pro-
cessing and translation of COX I mRNA (Barros et al., 2006).
However, we observed an overall reduction in the expression of
all 13 mitochondrially encoded proteins in AURKAIP1 knock-
down cell lines (Figure 4C), suggesting that this protein plays a
general role in mitochondrial translation that is not limited to
the synthesis of cytochrome oxidase. Further, no changes in the
level of COI mRNA were observed in the AURKAIP1 knock-
down cell line (Figure 4A). This observation clearly supports the
fact that mammalian mitochondrial genes do not contain introns
to be processed, unlike the mitochondrially encoded genes in
yeast. MRPS37 and MRPS38 are ribosomal small subunit pro-
teins that are clearly involved in translation; however, their spe-
cific roles in mammalian mitochondrial translation remain to be
discovered.
Frontiers in Physiology | Mitochondrial Research July 2013 | Volume 4 | Article 183 | 12
Koc et al. Mammalian mitochondrial ribosomes: revisited
The siRNA knock-down of MRPS39 (PTCD3) decreased the
activities of Complex III and Complex IV, possibly by directly
affecting mRNA binding to the mitochondrial ribosome, as
shown in our cross-linking experiments (Haque et al., 2011).
In fact, PTCD3 was identified as one of the mRNA-binding
proteins and IF3mt interacting proteins located near the mRNA-
binding path of the small subunit in crosslinking studies (Davies
et al., 2009). Although the majority of the MRPs forming the
platform of the mRNA-binding path in the 28S subunit are
bacterial homologs (such as MRPS7, MRPS11, MRPS18, and
MRPS21), the shoulder region and the mRNA-gate of the 28S
subunit are mainly formed by mitochondrial-specific MRPs
(Smits et al., 2007; Christian and Spremulli, 2011; Koc and Koc,
2012). Therefore, it is possible that MRPS39 is one of the proteins
that forms the mRNA-binding path and interacts with the 5′-ends
of mitochondrial mRNAs.
MRPL58 was initially identified as immature colon carcinoma
transcript 1 (ICT1) because it was one of the transcripts differen-
tially expressed in colorectal tumors that deviate from the normal
maturation pathway in colon epithelium (Van Belzen et al., 1995,
1998). Later, it was discovered to be an unusual member of
a release factor family involved in termination of mitochon-
drial translation, possessing a codon-independent peptidyl-tRNA
hydrolase activity associated with the mitochondrial ribosome
(Richter et al., 2010). It was also recently reported that MRPL58
is essential for cell viability, because its knock-down resulted in
reduced cytochrome c oxidase activity and eventually lead to
apoptotic cell death (Handa et al., 2010).
The other new large subunit protein, MRPL59 (CRIF1), has
been identified as a transcription co-factor that controls the G1/S
phase of the cell cycle (Chung et al., 2003). It also negatively reg-
ulates the stability of a transcription factor, nuclear respiratory
factor 2, that stimulates the expression of many mitochondrial
proteins and proteins involved in oxidative damage (Kang et al.,
2010). The majority of these studies were performed using the
protein tagged at its amino terminus as the ectopically expressed
form of CRIF1; therefore, it is possible that the majority of the
tagged CRIF1 did not get incorporated into the 55S ribosome, due
to the masking of the mitochondrial targeting signal. This form of
the expressed protein could subsequently be translocated into the
nucleus. Another explanation could be that a very small fraction
of CRIF1 is located in the nucleus to manifest its function as a
transcription co-factor. However, when the tag is placed at pro-
tein’s carboxy terminus, this protein is targeted to mitochondria
(Chung et al., 2003). Recently, it has been reported to inter-
act with mitochondrial ATAD3 and the ribosome, confirming its
mitochondrial localization and assignment as a ribosomal large
subunit protein (He et al., 2012; Kim et al., 2012). Endogenous
levels of CRIF1 have been shown to be dramatically reduced in
epithelial cell cancers in thyroid and breast tissue, in agreement
with the possible mitochondrial dysfunction reported in many
different cancer types. In this study, we provided very strong
evidence for CRIF1 being a bona fide ribosomal protein and an
essential component of the mitochondrial translation machinery.
Given that the mitochondrial translational machinery and its
components are essential for the expression of OXPHOS sub-
units, studies related to the identification of new components of
the translational machinery and their specific roles in translation
have the utmost importance in understanding energy produc-
tion by OXPHOS. A completed picture of the mitochondrial
translation machinery will be important to assess mitochondrial
dysfunction manifested not only in neurodegenerative diseases,
aging, diabetes, and cancer, but also in acute and chronic cardio-
vascular diseases.
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